通过依赖阿迪波内克丁通路的AMPK激活来逆转神经病理,代谢功能障碍和电生理缺陷
Eric R McGregor1,2, Danny J Lasky3, Olivia J Rippentrop3
1Division of Geriatrics, Department of Medicine, SMPH, University of Wisconsin-Madison, Madison, WI.
bioRxiv : the preprint server for biology
|February 19, 2024
概括
阿迪波龙 (AR) 向大脑线粒体,清除神经纤维状结 (NFT) 并恢复神经元功能. 这种方法纠正了与病相关的代谢,细胞和电力缺陷.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 细胞的新陈代谢
背景情况:
- 大脑线粒体功能障碍与功能衰退有关,但直接的因果关系尚不清楚.
- 神经纤维状结 (NFTs) 是陶病的病理特征,有助于神经元功能障碍.
- 准线粒体通路为神经退行性疾病提供了潜在的治疗策略.
研究的目的:
- 为了研究AdipoRon (AR) 的有效性,一个阿迪波涅克丁受体激活剂,在缓解NFT病理和相关的神经元缺陷.
- 阐明AR对线粒体功能和神经元健康的影响背后的分子机制.
- 探索向阿迪波涅克丁受体治疗病症的潜力.
主要方法:
- 在病的模型中使用AdipoRon (AR) 进行线粒体向.
- 对酸水平和NFT负担的评估.
- 对关键信号通路的分析,包括AMPK,GSK3b,LC3,p62和JNK.
- 评估线粒体活动,ATP生产和脂质储存.
- 电生理学记录以评估神经元功能.
主要成果:
- 抗逆转录治疗有效清除了NFT并降低了酸水平.
- AR调节AMPK和GSK3b,影响病理.
- 诱导了溶解体通路 (LC3,p62),并且需要JNK激活来恢复神经元外生长.
- AR纠正了线粒体缺陷,包括ATP生产和脂质代谢.
- 电生理学异常,如改变静止电位和尖端配置文件,被逆转.
结论:
- 通过AR激活阿迪波涅克受体,通过向线粒体功能障碍,为病提供了一种新的治疗策略.
- 激素增长在线粒体健康,细胞维护 (溶酶体通路) 和神经元电活动之间建立了联系.
- 向阿迪波涅克丁受体通路提供了一个有前途的网络方法来解决复杂的神经退行性病理.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:25cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
01:26Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K